5月23日,亚盛医药(06855)发布公告,宣布公司将在2025年5月30日至6月3日于美国芝加哥举办的2025年美国临床肿瘤学会年会上,展示两项最新的临床研究进展。其中,APG-2575(lisaftoclax)治疗多种血液系统肿瘤的研究将以口头报告的形式发布,而APG-115(alrizomadlin)治疗实体瘤的研究则以壁报形式展示。在APG-2575的研究中,针对初治或既往接受过维奈克拉...
Source Link5月23日,亚盛医药(06855)发布公告,宣布公司将在2025年5月30日至6月3日于美国芝加哥举办的2025年美国临床肿瘤学会年会上,展示两项最新的临床研究进展。其中,APG-2575(lisaftoclax)治疗多种血液系统肿瘤的研究将以口头报告的形式发布,而APG-115(alrizomadlin)治疗实体瘤的研究则以壁报形式展示。在APG-2575的研究中,针对初治或既往接受过维奈克拉...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.